Lemaitre Vascular (LMAT) Tops Q1 EPS by 2c; Guides Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
LeMaitre Q1 2023 Financial Results
May 2, 2023 4:05 PM EDTBURLINGTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q1 2023 results, announced a $0.14/share quarterly dividend and provided guidance.
Q1 2023 Financial ResultsÂ
Sales $47.1mm, +19% (+22% organic) vs. Q1 2022Op. income $7.9mm, -1%Op. margin 17%Net income $6.0mm, flatEarnings per diluted share $0.27, -1%Valvulotomes (+29%), carotid patches (+17%), bovine grafts (+22%), allografts (+42%) and... More
